| Dermatitis
Analpram HC vs Adbry
Side-by-side clinical, coverage, and cost comparison for dermatitis.Deep comparison between: Analpram Hc vs Adbry with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsAdbry has a higher rate of injection site reactions vs Analpram Hc based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Adbry but not Analpram Hc, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Analpram Hc
Adbry
At A Glance
Topical
3-4 times daily
Topical corticosteroid / anesthetic
SC injection
Every 2-4 weeks
IL-13 antagonist
Indications
- Dermatitis
- Dermatitis
Dosing
Dermatitis Apply as a thin film to the affected area 3-4 times daily depending on severity; occlusive dressings may be used for psoriasis or recalcitrant conditions.
Dermatitis - Adults 600 mg SC loading dose (four 150 mg prefilled syringes or two 300 mg autoinjectors), then 300 mg SC every other week; after 16 weeks, adults below 100 kg who achieve clear or almost clear skin may reduce to 300 mg every 4 weeks.
Dermatitis - Pediatric Patients 12 Years and Older 300 mg SC loading dose (two 150 mg prefilled syringes), then 150 mg SC every other week using prefilled syringe.
Contraindications
- History of hypersensitivity to any component of the preparation
- Known hypersensitivity to tralokinumab-ldrm or any excipients in ADBRY
Adverse Reactions
Most common Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, skin atrophy, perioral dermatitis, striae, allergic contact dermatitis, miliaria, secondary infection, maceration of the skin
Most common (>=1%) Upper respiratory tract infections, conjunctivitis, injection site reactions, eosinophilia
Conjunctivitis and Keratitis Conjunctivitis (including allergic conjunctivitis), keratoconjunctivitis, keratitis (including ulcerative keratitis)
Pharmacology
Topical corticosteroid with anti-inflammatory, anti-pruritic, and vasoconstrictive actions; combined with pramoxine hydrochloride, a local anesthetic that stabilizes neuronal membranes to provide temporary relief from itching and pain.
IL-13 antagonist; tralokinumab-ldrm is a human IgG4 monoclonal antibody that specifically binds to IL-13 and blocks its interaction with IL-13Ralpha1 and IL-13Ralpha2 receptor subunits, inhibiting IL-13-induced proinflammatory cytokine, chemokine, and IgE release.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Analpram Hc
- Covered on 5 commercial plans
- PA (6/12) · Step Therapy (0/12) · Qty limit (0/12)
Adbry
- Covered on 5 commercial plans
- PA (10/12) · Step Therapy (5/12) · Qty limit (9/12)
UnitedHealthcare
Analpram Hc
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Adbry
- Covered on 4 commercial plans
- PA (5/8) · Step Therapy (0/8) · Qty limit (5/8)
Humana
Analpram Hc
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (0/3) · Qty limit (0/3)
Adbry
- Covered on 0 commercial plans
- PA (3/3) · Step Therapy (1/3) · Qty limit (3/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Analpram Hc.
Cost estimate not availableAdbry Bridge Care Program
Commercial or private insurance
Medicare, Medicaid, VA, TRICARE
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
Analpram HcView full Analpram Hc profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.